We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.88B
AUM Growth
-$1.57B
Cap. Flow
+$103M
Cap. Flow %
1.15%
Top 10 Hldgs %
15.32%
Holding
763
New
20
Increased
297
Reduced
294
Closed
39

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$28M
2
PRGO icon
Perrigo
PRGO
+$25.4M
3
J icon
Jacobs Solutions
J
+$23.4M
4
ICUI icon
ICU Medical
ICUI
+$21.3M
5
SSB icon
SouthState Bank Corp
SSB
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Healthcare 18.06%
3 Industrials 15.07%
4 Financials 12.92%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYX icon
26
NCR Voyix
VYX
$1.06B
$71.2M 0.8%
3,732,426
-648,642
-15% -$13.8M
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.07T
$67M 0.75%
245,231
+4,019
+2% +$1.26M
SPGI icon
28
S&P Global
SPGI
$126B
$66.6M 0.75%
197,561
-17,289
-8% -$6.16M
CMP icon
29
Compass Minerals
CMP
$1.24B
$65.7M 0.74%
1,857,704
+40,446
+2% +$2M
SPXC icon
30
SPX Corp
SPXC
$11B
$64.8M 0.73%
1,227,334
-7,224
-0.6% -$349K
OFIX icon
31
Orthofix Medical
OFIX
$455M
$64.7M 0.73%
2,749,921
+28,070
+1% +$804K
ITW icon
32
Illinois Tool Works
ITW
$81.4B
$63.5M 0.71%
348,353
-15,566
-4% -$3.11M
CVX icon
33
Chevron
CVX
$388B
$63.4M 0.71%
437,867
+14,879
+4% +$2.46M
KBR icon
34
KBR
KBR
$4.68B
$62.6M 0.7%
1,294,122
+32,399
+3% +$1.6M
AVY icon
35
Avery Dennison
AVY
$12.3B
$62.1M 0.7%
384,298
+5,065
+1% +$865K
ICUI icon
36
ICU Medical
ICUI
$3.93B
$61.2M 0.69%
372,264
+110,658
+42% +$21.3M
GL icon
37
Globe Life
GL
$13.5B
$60.7M 0.68%
622,799
+17,544
+3% +$1.72M
RTX icon
38
RTX Corp
RTX
$287B
$60.3M 0.68%
627,325
+8,246
+1% +$793K
ABT icon
39
Abbott
ABT
$180B
$58.4M 0.66%
537,609
-4,001
-0.7% -$454K
MDLZ icon
40
Mondelez International
MDLZ
$77.7B
$57.4M 0.65%
924,026
-9,668
-1% -$611K
SBCF icon
41
Seacoast Banking Corp of Florida
SBCF
$3.26B
$56.2M 0.63%
1,700,777
+106,500
+7% +$3.56M
FNV icon
42
Franco-Nevada
FNV
$41.4B
$55.9M 0.63%
425,114
+1,763
+0.4% +$261K
MRSH
43
Marsh
MRSH
$86.3B
$54.9M 0.62%
353,270
+40,379
+13% +$6.47M
JNJ icon
44
Johnson & Johnson
JNJ
$635B
$53.9M 0.61%
303,430
-6,503
-2% -$1.16M
COST icon
45
Costco
COST
$415B
$53.3M 0.6%
111,184
-2,483
-2% -$1.26M
RGA icon
46
Reinsurance Group of America
RGA
$15.7B
$53.2M 0.6%
453,187
-1,812
-0.4% -$210K
NOW icon
47
ServiceNow
NOW
$102B
$53M 0.6%
556,970
+134,960
+32% +$12.9M
MCHP icon
48
Microchip Technology
MCHP
$42.8B
$52.5M 0.59%
903,409
-16,052
-2% -$1.06M
EL icon
49
Estee Lauder
EL
$29B
$52.2M 0.59%
205,095
-13,366
-6% -$3.39M
KEYS icon
50
Keysight
KEYS
$54.5B
$50.9M 0.57%
369,509
-81,535
-18% -$11.6M

Similar funds

Segall Bryant & Hamill's Q2 2022 Portfolio in Review

As of Q2 2022, Segall Bryant & Hamill held 763 positions worth $8.88B, down 15% from $10.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2022 filing shows 20 new, 297 increased, 294 reduced and 39 closed positions. Its largest new stake was Perrigo: 684,450 shares worth $27.7M. The largest sale was Western Alliance Bancorporation, an estimated $35M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q2 2022 buy was Perrigo: 684,450 shares worth $27.7M.
  • Segall Bryant & Hamill added most to Unilever in Q2 2022, an estimated $28M increase.
  • Segall Bryant & Hamill's biggest Q2 2022 reduction was Western Alliance Bancorporation, cutting an estimated $35M.
  • Segall Bryant & Hamill fully exited Anaplan, Inc. in Q2 2022, selling an estimated $22.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.88B portfolio in Q2 2022.
  • Segall Bryant & Hamill opened 20 new positions and closed 39 in Q2 2022.
  • Segall Bryant & Hamill's portfolio value fell 15% quarter-over-quarter to $8.88B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2022, filed 15 Aug 2022.